Agios Reports Third Quarter 2015 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. LVS
7. SAP
8. CSX
9. LRCX
10. MRK

Go back to Agios Reports Third Quarter 2015 Financial Results

Agios Pharma (AGIO) Releases Initial AG-120 Data; Oppenheimer Reiterates Perform

November 9, 2015 9:28 AM EST

Oppenheimer reiterated a Perform rating on Agios Pharma (NASDAQ: AGIO) following initial data from an ongoing phase I trial of AG-120. AG-120 was generally well tolerated in advanced solid tumors including glioma, IHCC and chondrosarcoma, with no dose-limiting toxicities (DLTs) observed based on the... More

Agios Pharma (AGIO) Posts Wider Q3 Loss

November 5, 2015 8:01 AM EST

Agios Pharma (NASDAQ: AGIO) reported Q3 EPS of ($1.08), $0.20 worse than the analyst estimate of ($0.88). Revenue for the quarter came in at $5.8 million versus the consensus estimate of $17.21 million.

Cash, cash equivalents and marketable securities as of September 30, 2015 were $408.0 million, compared to $467.4 million as... More